The Dow Jones Industrial Average closed up more than 500 points on Tuesday after news that biotech company Novavax had begun human trials for a potential COVID-19…
The Dow closed just shy of 25,000 on Tuesday, for a time crossing what analysts have identified as an important psychological barrier to economic recovery after the coronavirus pandemic.
